Some studies were also conducted in patients with obesity or metabolic syndrome, showing that acute administration of β-glucan enriched foods dose-dependently increases PYY [39], increases CCK without affecting ghrelin (8), or decreases GIP without affecting insulin, GLP-1, or ghrelin [40]. Here, GHRL is linked to obesity disorder.